Andrea Montesel

Andrea Montesel

Auto-generated profile, based on publicly available information

Andrea Montesel

Department of Ophthalmology, University of Lausanne, Fondation Asile des Aveugles, Jules Gonin Eye Hospital, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2020 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio
AMAndrea Montesel
Andrea Montesel
FSFouad El Sayyad
Fouad El Sayyad
RBRafael Ignacio Barraquer
Rafael Ignacio Barraquer
FAFrancisco Arnalich-Montiel
Francisco Arnalich-Montiel
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio
Corneal graft surgery is one of the most successful forms of human solid-tissue transplantation, and nowadays, there is a worldwide expansion of the surgical volume of corneal grafts. This surgery is continuously evolving, with new surgical techniques and postoperative treatments that have considerably increased the chance of survival for the grafts. Despite the high rate of success, corneal transplantation is still complicated by a relevant risk of graft failure. This study investigates the causes that lead to the failure of the different corneal graft surgical techniques and provides an updated synthesis on this topic. A comprehensive review of the main pathological pathways that determine the failure of corneal grafts is provided, analysing the main risk factors and disclosing the survival rates of the principal form of corneal grafts. Our results revealed that penetrating keratoplasty has higher failure rates than lamellar keratoplasty, with immunological rejection being the leading cause of graft failure, followed by late endothelial failure (LEF) and ocular surface disorders. Postoperative glaucoma and dehiscence of the surgical wound represent other important causes of failure. Endothelial keratoplasty showed the lowest rates of failure in the mid-term, with LEF, detachment of the graft and primary graft failure representing the most common pathological reasons for failure.

9 January 2021 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
AGAlba Gómez‐Benlloch
Alba Gómez‐Benlloch
AMAndrea Montesel
Andrea Montesel
LPLuis Pareja‐Aricò
Luis Pareja‐Aricò
DMDavid Mingo‐Botín
David Mingo‐Botín
RMRalph Michael
Ralph Michael
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio

1 January 2021 in Survey of Ophthalmology
Verified
Journal Article
Closed access
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio
MBManinder Bhogal
Maninder Bhogal
MAMarcus Ang
Marcus Ang
MZMohammed Ziaei
Mohammed Ziaei
SRScott Robbie
Scott Robbie
JAJorge L. Alió
Jorge L. Alió

1 May 2025 in Retina
Verified
Journal Article
Closed access
AMAndrea Montesel
Andrea Montesel
SSSagnik Sen
Sagnik Sen
EPElla Preston
Ella Preston
PPPraveen J. Patel
Praveen J. Patel
JHJosef Huemer
Josef Huemer
IYIan Yeung
Ian Yeung
Purpose: To report 1-year real-world evidence on intraocular inflammation (IOI) adverse events in patients undergoing faricimab therapy in a tertiary care hospital. Methods: A retrospective review of electronic medical records was conducted for patients receiving faricimab treatment for neovascular age-related macular degeneration and diabetic macular edema at Moorfields Eye Hospital between September 1, 2022, and August 31, 2023. The primary outcome was the incidence of IOI (excluding endophthalmitis). Results: Two thousand three hundred and eighteen eyes from 1,860 patients were included and underwent a total of 10,297 injections. A total of 20 eyes (16 patients) had ≥1 adverse event of IOI. Estimated incidence of IOI was 0.19% per injection (95% confidence interval, 0.12–0.30), 0.86% per eye (95% confidence interval 0.53–1.33), and 0.86% per patient (95% confidence interval, 0.49–1.39). Intraocular inflammation mostly occurred within the first injections (median 3.5 injections, range 1–10). All cases presented with anterior uveitis and were associated with vitritis in four eyes (20%). No cases of posterior uveitis or evidence of retinal vascular occlusion were reported. There was no statistically significant difference between the mean visual acuity before and after IOI event (0.40 and 0.378 logarithm of minimum angle of resolution, respectively, P = 0.26). Conclusion: In this real-world report, faricimab was well tolerated with an incidence of IOI-related adverse events consistent to that observed in registration trials. The adverse events were generally mild and had a favorable prognosis.

3 July 2019 in Cornea
Verified
Journal Article
Closed access
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio
AMAndrea Montesel
Andrea Montesel
VHVivian Ho
Vivian Ho
MBManinder Bhogal
Maninder Bhogal
Purpose: To evaluate the safety and efficacy of the treatment of secondary graft failure in penetrating keratoplasty (PK) by performing Descemet membrane endothelial keratoplasty (DMEK) without host descemetorhexis. Methods: This is a retrospective case series study of 8 eyes from 8 patients who underwent non host Descemet membrane stripping DMEK surgery under a previously failed PK. The DMEK graft diameter was either matched or 0.25 to 0.5 mm undersized in relation to the PK diameter. Six-month postoperative data are presented. Primary outcome measures were safety and anatomical success. Results: No intraoperative complications were registered. Postoperatively, 1 case developed a PK host–donor junction dehiscence in relation to a previous early suture removal, requiring PK resuturing and DMEK rebubbling. Only 1 additional case required DMEK rebubbling. No primary graft failure was detected, and all cases achieved full PK transparency within 2 weeks. Corrected distance visual acuity improved from a median of counting fingers (CF-0.2) to 0.57 (0.05–0.7). Median central corneal thickness improved from 650.5 (497–897) to 464 (372–597) μm. Median endothelial cell density was 1080 (581–2043) cells/mm2. Rebubbling rate (25%) was lower than that previously reported. All patients had extensive preoperative ocular comorbidity. Conclusions: DMEK under PK without host descemetorhexis is a feasible surgical alternative for the treatment of graft failure after PK. It is associated with equivalent levels of efficacy and safety compared with Descemet membrane stripping DMEK techniques but simplifies the surgical procedure and avoids potential intraoperative complications associated with Descemet stripping. Further studies with a larger sample and a longer follow-up are necessary to confirm our preliminary outcomes.

5 August 2020 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
AMAndrea Montesel
Andrea Montesel
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio
PRPilar Yébana Rubio
Pilar Yébana Rubio
JBJorge L. Alió del Barrio
Jorge L. Alió del Barrio
Purpose: To investigate indications, outcomes and changes in clinical patterns of keratoplasty surgery in a Spanish tertiary eye center. Setting: Vissum Instituto Oftalmológico, Alicante, Spain. Methods: A retrospective review was performed on clinical records of patients that underwent any kind of corneal transplant from 2001 to 2017 in the study center. Inclusion criteria involved the presence of detailed preoperative examination, surgical report and at least 12 months follow-up after the surgery. A statistical analysis was performed on the indications for keratoplasty, survival rates, type of graft failures, and visual outcomes. Results: A total of 907 keratoplasties procedures were identified. About 432 penetrating keratoplasty (PK), 148 deep anterior lamellar keratoplasty (DALK), and 134 endothelial keratoplasty (EK) met the inclusion criteria. Cumulative survival rate ranged from 94% to 69% in a 1-year period and from 85% to 45% in a 5-years period according to the different graft types. The main cause for failure was immunological rejection for PK, surface diseases for DALK and primary graft failure for EK. Postoperative visual function improved for all the surgical techniques. Conclusion: Corneal transplant is a challenging surgery still complicated by a relevant risk of failure. Our study offers a useful opinion of the current trends on keratoplasty in our country, where the outcomes of the grafts differ considerably in relation to the indications and the different surgical techniques, with lamellar procedures that showed higher rates of success and better visual outcomes than full-thickness grafts.